Literature DB >> 16756849

[Out-patient treatment of deep-vein thrombosis].

J M Calvo-Romero1, E M Lima-Rodríguez.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16756849      PMCID： PMC8207940          DOI： 10.1157/13088883

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  10 in total

1.  Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis.

Authors:  M Meignan; J Rosso; H Gauthier; F Brunengo; S Claudel; L Sagnard; P d'Azemar; G Simonneau; B Charbonnier
Journal:  Arch Intern Med       Date:  2000-01-24

Review 2.  Clinical practice. Treatment of deep-vein thrombosis.

Authors:  Shannon M Bates; Jeffrey S Ginsberg
Journal:  N Engl J Med       Date:  2004-07-15       Impact factor: 91.245

3.  Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study.

Authors:  H Boccalon; A Elias; J J Chalé; A Cadène; S Gabriel
Journal:  Arch Intern Med       Date:  2000-06-26

Review 4.  Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Harry R Büller; Giancarlo Agnelli; Russel D Hull; Thomas M Hyers; Martin H Prins; Gary E Raskob
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

5.  Deep venous thrombosis: a new task for primary health care. A randomised economic study of outpatient and inpatient treatment.

Authors:  Karin Bäckman; Per Carlsson; Magnus Kentson; Sören Hansen; Leif Engquist; Claes Hallert
Journal:  Scand J Prim Health Care       Date:  2004-03       Impact factor: 2.581

Review 6.  Outpatient therapy with low molecular weight heparin for the treatment of venous thromboembolism: a review of efficacy, safety, and costs.

Authors:  Jodi B Segal; Dennis T Bolger; Mollie W Jenckes; Jerry A Krishnan; Michael B Streiff; John Eng; Leonardo J Tamariz; Eric B Bass
Journal:  Am J Med       Date:  2003-09       Impact factor: 4.965

7.  The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy.

Authors:  Marc A Rodger; Christine Gagné-Rodger; Heather E Howley; Marc Carrier; Doug Coyle; Philip S Wells
Journal:  Thromb Res       Date:  2003       Impact factor: 3.944

8.  Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.

Authors:  M M Koopman; P Prandoni; F Piovella; P A Ockelford; D P Brandjes; J van der Meer; A S Gallus; G Simonneau; C H Chesterman; M H Prins
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 91.245

9.  Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin.

Authors:  L Harrison; J McGinnis; M Crowther; J Ginsberg; J Hirsh
Journal:  Arch Intern Med       Date:  1998-10-12

10.  Should patients with deep vein thrombosis alone be treated as those with concomitant asymptomatic pulmonary embolism? A prospective study.

Authors:  Manuel Monreal; Harry Büller; Anthonie Wa Lensing; Montserrat Bonet; Javier Roncales; Jordi Muchart; Manuel Fraile
Journal:  Thromb Haemost       Date:  2002-12       Impact factor: 5.249
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.